These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
359 related articles for article (PubMed ID: 29357265)
1. Characterization of the "Frequent Exacerbator Phenotype" in Bronchiectasis. Chalmers JD; Aliberti S; Filonenko A; Shteinberg M; Goeminne PC; Hill AT; Fardon TC; Obradovic D; Gerlinger C; Sotgiu G; Operschall E; Rutherford RM; Dimakou K; Polverino E; De Soyza A; McDonnell MJ Am J Respir Crit Care Med; 2018 Jun; 197(11):1410-1420. PubMed ID: 29357265 [TBL] [Abstract][Full Text] [Related]
2. Prognostic Value of Frequent Exacerbations in Bronchiectasis: The Relationship With Disease Severity. Martinez-Garcia MÁ; Athanazio R; Gramblicka G; Corso M; Cavalcanti Lundgren F; Fernandes de Figueiredo M; Arancibia F; Rached S; Girón R; Máiz Carro L; de la Rosa Carrillo D; Prados C; Olveira C Arch Bronconeumol (Engl Ed); 2019 Feb; 55(2):81-87. PubMed ID: 30119935 [TBL] [Abstract][Full Text] [Related]
3. The independent contribution of Araújo D; Shteinberg M; Aliberti S; Goeminne PC; Hill AT; Fardon TC; Obradovic D; Stone G; Trautmann M; Davis A; Dimakou K; Polverino E; De Soyza A; McDonnell MJ; Chalmers JD Eur Respir J; 2018 Feb; 51(2):. PubMed ID: 29386336 [No Abstract] [Full Text] [Related]
4. Antimicrobial peptides, disease severity and exacerbations in bronchiectasis. Sibila O; Perea L; Cantó E; Shoemark A; Cassidy D; Smith AH; Suarez-Cuartin G; Rodrigo-Troyano A; Keir HR; Oriano M; Ong S; Vidal S; Blasi F; Aliberti S; Chalmers JD Thorax; 2019 Sep; 74(9):835-842. PubMed ID: 31278172 [TBL] [Abstract][Full Text] [Related]
5. Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients. Kawamatawong T; Onnipa J; Suwatanapongched T Int J Chron Obstruct Pulmon Dis; 2018; 13():761-769. PubMed ID: 29535516 [TBL] [Abstract][Full Text] [Related]
6. Five-Year Outcomes among U.S. Bronchiectasis and NTM Research Registry Patients. Aksamit TR; Locantore N; Addrizzo-Harris D; Ali J; Barker A; Basavaraj A; Behrman M; Brunton AE; Chalmers S; Choate R; Dean NC; DiMango A; Fraulino D; Johnson MM; Lapinel NC; Maselli DJ; McShane PJ; Metersky ML; Miller BE; Naureckas ET; O'Donnell AE; Olivier KN; Prusinowski E; Restrepo MI; Richards CJ; Rhyne G; Schmid A; Solomon GM; Tal-Singer R; Thomashow B; Tino G; Tsui K; Varghese SA; Warren HE; Winthrop K; Zha BS Am J Respir Crit Care Med; 2024 Jul; 210(1):108-118. PubMed ID: 38668710 [No Abstract] [Full Text] [Related]
7. Non cystic fibrosis bronchiectasis: A longitudinal retrospective observational cohort study of Pseudomonas persistence and resistance. McDonnell MJ; Jary HR; Perry A; MacFarlane JG; Hester KL; Small T; Molyneux C; Perry JD; Walton KE; De Soyza A Respir Med; 2015 Jun; 109(6):716-26. PubMed ID: 25200914 [TBL] [Abstract][Full Text] [Related]
8. Association between bronchiectasis exacerbations and longitudinal changes in FEV Aksamit TR; Lapinel NC; Choate R; Feliciano J; Winthrop KL; Schmid A; Wu J; Fucile S; Metersky ML; Respir Med; 2024 Jul; 228():107660. PubMed ID: 38734153 [TBL] [Abstract][Full Text] [Related]
9. The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study. Dicker AJ; Lonergan M; Keir HR; Smith AH; Pollock J; Finch S; Cassidy AJ; Huang JTJ; Chalmers JD Lancet Respir Med; 2021 Aug; 9(8):885-896. PubMed ID: 33961805 [TBL] [Abstract][Full Text] [Related]
10. [Respiratory pathogen spectrum in pulmonary exacerbation of bronchiectasis in adults and its association with disease severity]. Gao YH; Guan WJ; Zhu YN; Chen RC; Zhang GJ Zhonghua Jie He He Hu Xi Za Zhi; 2019 Apr; 42(4):254-261. PubMed ID: 30955282 [No Abstract] [Full Text] [Related]
11. Mannose-binding lectin deficiency and disease severity in non-cystic fibrosis bronchiectasis: a prospective study. Chalmers JD; McHugh BJ; Doherty C; Smith MP; Govan JR; Kilpatrick DC; Hill AT Lancet Respir Med; 2013 May; 1(3):224-32. PubMed ID: 24429128 [TBL] [Abstract][Full Text] [Related]